← FDA Drug Approvals (Drugs@FDA)
ETODOLAC
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2003-03-13
Drug application
- FDA Application #
ANDA076174- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ETODOLAC
- Generic name
- ETODOLAC
- Active ingredients
- ETODOLAC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TARO
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- First approval
- 2003-03-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown